BlackRock Japan’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

BlackRock Japan’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-6,950	Closed	-$371K	–	1586
2016 Q1	$371K	Sell	6,950 -272	-4%	-$20.1K	﹤0.01%	773
2015 Q4	$816K	Buy	7,222 +464	+7%	+$51.1K	﹤0.01%	724
2015 Q3	$795K	Buy	6,758 +5,776	+588%	+$754K	﹤0.01%	715
2015 Q2	$76K	Buy	982 +767	+357%	+$50.3K	﹤0.01%	1009
2015 Q1	$12K	Buy	+215	New	+$9.13K	﹤0.01%	1232

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

BlackRock Japan's ANAC Position: Q2 2016 in Review

BlackRock Japan sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 6,950 shares — an estimated $371K sold.

BlackRock Japan first reported a position in ANAC in Q1 2015 and held it in 5 quarters. The position peaked at $816K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

BlackRock Japan reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
BlackRock Japan sold 6,950 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $371K.
BlackRock Japan first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 5 quarters.
BlackRock Japan's ANACOR PHARMACEUTICALS INC COM position peaked at $816K in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on BlackRock Japan's 13F filing for Q2 2016, filed 10 Aug 2016.